Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: Para ti, para mi, para nosotros (P3)
Total 0 results
Nothing found
Sponsors and Collaborators
Australian Childhood Foundation
Laboratoires Iprad-Vegebom
Resurge Therapeutics Inc.
Dr Gilles DUCHEIX/ Center of clinical pharmacology/CIC Inserm-501 - Investigator
Zhijun Sun
Health Holding Company, Hail Health Cluster, Saudi Arabia
Epicentre, Paris, France.
Kettering Foundation
wenbinlu
Méthodologie et Evaluation pour la Recherche clinique et Epidémiologique sur le VIH en Afrique (MEREVA)
NATURAmedicatrix Sàrl
Jain, Isha, B.A., Massachusetts General Hospital, Harvard Medical School
Sociedad Española de Arteriosclerosis
Paul W. Read, MD
Prader-Willi Syndrome Association of Australia
Carlos III Health Institute
Brigham and Womens' Hospital, Center for Surgery and Public Health
Remedy Institute
The Depressive and Bipolar Disorder Alternative Treatment Foundation
Sonogenix
View Full List
Medical Conditions
Psychoactive Substance Use
Malignant Tumor of Extrahepatic Bile Duct
Neurobehavioral Manifestation
Refractory B-Lineage Lymphoma
Stroke Recrudescence
Spinocerebellar Ataxia Genotype Type 3
Mycobacterium Avium Complex Infections
Ankle Trauma
Apneic; Oxygenation
Escape Room Games and Role Playing Gamification
Cell Senescence
Hernia,Ventral
Intervention Studies
Lymphoblastic Lymphoma
Stage III Childhood Anaplastic Large Cell Lymphoma
Adherence to In-Office Glaucoma Evaluation Appointment
Pregnancy; Accident
Stage IIIB Esophageal Adenocarcinoma
Relapsed/Refractory Diffuse Large B-cell Lymphoma
Marginal Zone B-cell Lymphoma
View Full List
Drug Interventions
FRSW107
Fortum (Ceftazidime for injection USP) Glaxo Smith Kline Pharmaceuticals Limited
Optiva artificial tear by Allergan
Omeprazole 40 mg
Fenofibric acid 135mg
Epalrestat
Lansoprazole 15mg QD
SBI-087
Irinotecan
Low molecular weight Heparin as standard of care treatment
Oral Aztreonam
300 mg of caffeine citrate infusion
Everolimus
Fostamatinib
Gadoteridol (ProHance)
Triple therapy
Colecalciferol D3 (Vigantol Oil)
ART-123
LINjeta U-100 Insulin
Atezolizumab (MPDL3280A), an engineered anti-PD-L1 antibody
View Full List
CROs by country
Contract Research Organizations in Bahamas
Contract Research Organizations in Burkina Faso
Contract Research Organizations in Cameroon
Contract Research Organizations in Ecuador
Contract Research Organizations in El Salvador
Contract Research Organizations in Ethiopia
Contract Research Organizations in Guatemala
Contract Research Organizations in Indonesia
Contract Research Organizations in Lebanon
Contract Research Organizations in Rwanda
Contract Research Organizations in Switzerland
Contract Research Organizations in Tunisia
Contract Research Organizations in Zimbabwe
CRO list by country
CROs in Croatia
BiTrial Clinical Research
Sermon CRO
PrimeVigilance
IQVIA
PPD
Dokumeds
SanaClis
PSI
OCT Clinical
DNA technologies
All CROs in Croatia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe